A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

Summary

The purpose of this study is to evaluate how well LY4256984 is tolerated and what side effects may occur in participants with sporadic amyotrophic lateral sclerosis (ALS). The study drug will be administered intrathecally (IT) into the spine. Blood tests will be performed to check how much LY4256984 gets into the bloodstream and how long it takes the body to eliminate it.

Timeline

Start

2025-08-05

Primary completion

2027-08

Completion

2027-09

Drugs

Indications